Mental Health
4 Early-Stage Mental Health Startups Targeting Specific Care Gaps
DealBio tracks early-stage mental health startups across Europe and North America. These 4 are building condition-specific products across emotional health, insomnia, OCD, preventive mental health for children, and addiction recovery.
- Digital Health
- Consumer Health
- Digital Therapeutics
- AI Health
Mental-health products are becoming more condition-specific, with startups building around defined disorders, age groups and moments of need rather than a single general-purpose app model.
That leads to different care and distribution models, including prescribed digital treatment, consumer hardware, between-session support, school-based prevention and addiction recovery.
At a Glance
- AnoriaUnited States2026Emotion-sensing wearable
- Di & CareFrance2023Prescribed digital therapy for insomnia
- ObsessLessNetherlands2025Between-session OCD support
- Sun FlowerUnited States2024Continuous digital support for sobriety
01
Anoria
Building a wearable that reads emotions to improve emotional intelligence.
- Country
United States- Founded
- 2026
- Sector
- Consumer health
- Funding stage
- Seed or earlier
- Founders
Why Anoria stands out
Anoria is building a dedicated emotional-health wearable using audio and biometric sensing. The startup entered Y Combinator’s Spring 2026 batch and put early prototypes into real-world use within two months.
Founder Michael Belhassen previously worked on the iPhone 17 Pro enclosure at Apple, bringing product-development experience from consumer hardware.
What Anoria is building
Anoria combines audio and biometric sensing in a bracelet designed to estimate emotional state and return a simplified “Flow Score.” The product is intended to help users recognize patterns in stress, communication and emotional regulation.
Anoria is designed to turn passive audio and biometric signals into feedback on emotional state, stress and communication patterns through daily wear.
Building Noxxea, a digital medicine for chronic insomnia.
- Country
France- Founded
- 2023
- Sector
- Digital health
- Funding stage
- Seed or earlier
Why Di & Care stands out
Noxxea is CE-marked, prescribed by physicians and had reached more than 1,000 patients in 2026, placing Di & Care within a clinical treatment pathway rather than a general wellness model.
In the REST-NOXXEA study, insomnia severity fell by 7.32 points and 79.3% of participants finished below the moderate-to-severe range, providing an early treatment signal.
What Di & Care is building
Noxxea delivers a four-week digital cognitive behavioral therapy program for chronic insomnia on a smartphone. The treatment structures sleep restriction, stimulus control and behavioral exercises into a prescription pathway.
With Noxxea already prescribed by physicians, Di & Care is using clinical evidence and CE marking to support broader adoption and reimbursement in insomnia care.
Offering an AI companion app for OCD support between therapy sessions.
- Country
Netherlands- Founded
- 2025
- Sector
- Consumer health
- Funding stage
- Seed or earlier
- Founders
Why ObsessLess stands out
The paid ObsessLess app has more than 5,000 installs. Before starting the startup, co-founder Mourice Schuurmans built an OCD community of more than 20,000 people.
ObsessLess has also received UtrechtInc support and non-dilutive funding. The existing OCD community gives the startup an early channel for product feedback and distribution.
What ObsessLess is building
ObsessLess combines an AI companion called Ollie with exposure and response prevention exercises, acceptance and commitment therapy tools, crisis-support features and peer community access.
The app is positioned between therapy sessions rather than as a replacement for specialist care, giving users tools to use when compulsions and anxiety occur outside the clinic.
Building a sobriety platform combining peer support, AI, and therapy.
- Country
- United States
- Founded
- 2024
- Sector
- Consumer health
- Funding stage
- Seed or earlier
- Founders
Why Sun Flower stands out
Sun Flower reached $1 million in annual recurring revenue within 10 months and grew to more than 100,000 monthly active users in under six months.
Founder Koby Conrad is a repeat Y Combinator founder with prior consumer-startup experience.
What Sun Flower is building
Sun Flower combines peer support, AI and therapy in one sobriety platform. The aim is to provide help between meetings and clinical sessions, when relapse risk can rise and conventional support may not be immediately available.
The platform extends support between formal care touchpoints by combining community, software and access to professional care in one product.
Deal Sourcing for Investors
Looking for More Startups Like These?
DealBio helps investment teams discover, research, and monitor early-stage healthcare and life sciences startups aligned with their investment criteria.
Mental health is becoming more condition-specific
These startups enter mental health through different moments of need: prescribed insomnia treatment, support between OCD therapy sessions, school-based prevention, daily emotional monitoring and sobriety support.
That makes distribution as important as product design. Physician prescribing, school partnerships, established condition-specific communities and repeat daily use each create a different route to adoption.
Methodology
DealBio selected these startups from its coverage of early-stage health and longevity startups, focusing on mental-health products with distinct target users, treatment contexts and business models. The selection spans consumer hardware, prescribed digital therapy, AI support, preventive gaming and addiction care.
DealBio builds its Startup Briefs using publicly available startup materials, ecosystem sources, market references and professional profiles.